Notice of EGM

Advanced Medical Solutions Grp PLC
12 February 2002


For Immediate Release:                                 Tuesday, 12 February 2002



                         Advanced Medical Solutions Group plc

          Extraordinary General Meeting Requisitioned for 5 March 2002

          Recommendation of Board to Vote 'NO' to the proposed resolution

Winsford, Cheshire: Advanced Medical Solutions Group plc ('AMS'), the medical
device company, is today posting a circular to shareholders giving notice of an
extraordinary general meeting ('EGM') to be held on Tuesday, 5 March 2002.

A nominee acting on behalf of Advance Value Realisation Company Limited ('AVRC
'), which holds shares in AMS has requisitioned the EGM.  The recommendation of
the Board of AMS to shareholders is to vote 'NO' to the resolution proposed by
AVRC calling for the Company to put itself up for sale.

In summary, the circular highlights the following reasons to vote 'NO' to the
resolution:

•       Strategic Focus.  Following the £7 million fund raising in January 2000,
the new management of AMS has created a solid platform for growth. AMS is to
focus on 1) higher margin, active products which speed tissue repair and 2)
tissue engineering.  Patents in the identified areas are being put in place.

•       Financial Control. Losses continue to be reduced.  The Interim results
for 2001 show that losses had been halved to £0.9 million and that cash flow was
neutral in the same period.

•       Partnerships with major players.  AMS has entered into partnership
agreements with major, international companies such as 3M, Coloplast, Johnson &
Johnson, Novartis and Smith & Nephew.  These partners will work with AMS and
enable it to meet its strategy for growth.

•       Future Growth.  The Board has identified a number of opportunities to
assist with the future growth of the Group.  These opportunities are being
evaluated with respect to their ability to accelerate growth and shareholder
value.

Additionally:

•       AVRC's proposal could damage AMS's value.

Uncertainty surrounding an impending sale will impact upon the perception of the
Group's stability and as such could harm relationships with existing partners.

•       AVRC's strategy is short term.

AVRC proposes to seek the consent of its shareholders to wind itself up in 2003,
its interests are therefore short term and are opposed to those of the other
shareholders of AMS.

Commenting on the proposed resolution, Geoffrey Vernon, Chairman of AMS, said:

'We see this as a totally inappropriate use of one shareholder's right to
requisition an extraordinary general meeting of all shareholders'.

'AMS has a focussed strategy for growth, with strong partnerships with major
medical companies.  It now has the ability to move into the higher margin areas,
with appropriate partnerships in place'.

'The Group finished 2001 well in line with market expectations and the Board is
confident about the prospects for 2002.  We are also in advanced stages of
negotiation on a number of significant partnership agreements, particularly with
respect to the anti-bleed gel and the silver-fibre technology'.

'Against this background one shareholder is seeking to impose its short term
goals on the majority of shareholders and in doing so is actively harming your
Company.  By publicly putting itself up for sale, relationships with AMS's major
partners could be harmed, diminishing shareholder value'.

'Your Board, which has been advised by Robert W. Baird, is of the opinion that
the Resolution is NOT in the best interests of your Company or the Shareholders
going forward and REJECTS the Resolution proposed.'

The extraordinary general meeting of AMS will be held at The Blue Cap, 520
Chester Road, Sandiway, Northwich CW8 2DN at 11.00 am on 5 March 2002 as set out
in the circular distributed to shareholders today.  Copies of the circular are
available from The Company Secretary, Advanced Medical Solutions Group plc Road
Three, Winsford Industrial Estate, Winsford, Cheshire, CW7 3PD.



                                    - ENDS -


Advanced Medical Solutions Group plc                    Tel: [phone]

Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Robert W. Baird                                       Tel:  [phone]
Shaun  Dobson / Tim Richardson

Buchanan Communications                                Tel: [phone]
Nicola How / Fergus Mellon





                      This information is provided by RNS
            The company news service from the London Stock Exchange